Nav: Home

Combination of cells and genes repairs damaged heart tissues in animal models of MI

June 01, 2016

Putnam Valley, NY. (June 1, 2016) - Researchers at the University of Utah compared the therapeutic potential of umbilical cord-derived sub-epithelial cells (UC-SECs), bone marrow-derived mesenchymal stem cells (BM-MSCs) and induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) -- all derived from human tissue -- along with genes (S100a1 and SDF-1a) and growth factor (VEGF165) to evaluate how injected biologics might enhance cardiac function in mice modeled with myocardial infarction (MI; commonly referred to as heart attack). The study revealed a range of beneficial results.

According to study co-author Dr. Amit N. Patel, director of cardiovascular regenerative medicine at the University of Utah and section editor for Cell Transplantation, the use of cell -- and gene-based therapeutics to preserve cardiac function have made considerable advancements over the past several years, with a variety of genes and cells proposed as therapeutic options because they possess multi-potency and therapeutic potential.

"Our goal was to simultaneously compare cells and genes in a pre-clinical ischemic heart model," said Dr. Patel. "The study was a unique approach to using multiple human cell and gene-based therapies and demonstrated that, depending on which aspect of cardiac recovery is being evaluated -- scar remodeling, improvement in contractile function, angiogenesis (new blood vessel growth) or inflammation -- a different biological may be best suited. There were no safety issues related to the biologics, and no gross tumors or other abnormalities on histology."

The study investigated which cells or biologics demonstrated the best results for a number of cardiac-related problems, including cardiac function and scarring. Scarring was of interest, said the researchers, because there is currently no approved therapy to reverse scar formation in the damaged heart or to replace scar tissue with new cardiac muscle cells (cardiomyocytes).

The authors noted that scar remodeling was best addressed by using UC-SECs, yet both S100a1 and SDF1a also demonstrated significant scar reduction when compared to controls and other biologics. Contractile function was most significantly improved by injecting hiPSC-CMs or S100a1 followed by UC-SECs. Angiogenesis was most significant in the group treated with growth factor (VEGF).

"The current study demonstrated that multiple cell types and genes, injected into a mouse model of MI, can positively alter various aspects of cardiac function and scarring for up to 12 weeks post-MI," concluded the researchers. "Future studies should aim to evaluate dose and combination therapies in order to decipher the most clinically applicable treatment."

Dr. Amit N. Patel, Director
Cardiovascular Regenerative Medicine
University of Utah
30 N 1900 E SOM 3c127
Salt Lake City UT 84132
Tel: 801-587-7946
Fax: 801-585-3936

Citation: Winters AA, Bou-Ghannam S, Thorp H, Hawayek JA, Atkinson DL, Bartlett CE, Silva FJ, Hsu EW, Moreno AP, Grainger DA, Patel AN. Evaluation of Multiple Biological Therapies for Ischemic Cardiac Disease. Appeared or available on-line: May 10, 2016.

This study, scheduled to be published later this year in a special cardiovascular issue of Cell Transplantation, is currently freely available on-line as an unedited early e-pub at:

The Co-Editors-in-Chief for CELL TRANSPLANTATION are at the Department of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, FL, USA and the Center for Neuropsychiatry, China Medical University Hospital, TaiChung, Taiwan. Contact: Paul R. Sanberg at, Shinn-Zong Lin at, or Associate Editor Samantha Portis at

Cell Transplantation Center of Excellence for Aging and Brain Repair

Related Myocardial Infarction Articles:

Discovery of cells that heal cardiac damage after infarction
Researchers at Cima and the Clinica Universidad de Navarra (Spain) have led an international study identifying the cardiac cells responsible for repairing the damage to this organ after infarction.
CHOP researchers find MIS-C associated with myocardial injury
Using sensitive parameters to assess cardiac function, researchers at Children's Hospital of Philadelphia (CHOP) have found that cardiac involvement in multisystem inflammatory syndrome in children (MIS-C) differs from Kawasaki disease (KD) and is associated with myocardial injury.
Heart attack modeled with human stem cells
A model of ischemic heart disease was developed using human induced pluripotent stem cells (hiPSC).
The relationship between lifetime drinking and non-fatal acute myocardial infarction
New research from the Prevention Research Center of the Pacific Institute for Research and Evaluation suggests that the impact of alcohol consumption on coronary heart disease may be underestimated.
The relationship between mean platelet volume and in-hospital mortality in geriatric patients with ST segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.
Epicardial coronary artery abnormalities that do not result in myocardial ischemia
What to Do with Epicardial Coronary Artery Abnormalities That do not Result in Myocardial Ischemia?
Dose-dependent effects of esmolol-epinephrine combination therapy in myocardial ischemia
Animal studies on cardiac arrest found that a combination of epinephrine with esmolol attenuates post-resuscitation myocardial dysfunction.
Renal infarction is associated with acute kidney injury in patients with cardiac amyloidosis
Systemic amyloidosis is a major cause of renal injury, mostly due to direct kidney damage caused by deposits of abnormal protein called amyloid, in the kidney parenchyma.
Anesthetic-induced myocardial conditioning: Molecular fundamentals and scope
The objective of this study was to investigate the role that miRNAs play in the cardioprotective effect of halogenated anesthetics.
A role for circadian enhancers to prevent myocardial injury in the perioperative setting
The current study demonstrates a deleterious effect of midazolam administration prior to myocardial ischemia and reveals reduced circadian protein Period 2 (PER2) levels as the underlying mechanism.
More Myocardial Infarction News and Myocardial Infarction Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at     You can read The Transition Integrity Project's report here.